CRBU

CARIBOU BIOSCIENCES INC

CRBU·142038108·US·Common Stock·Healthcare - Biotechnology-Activist

CRBU (CARIBOU BIOSCIENCES INC) is held by 84 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($13.8M), VANGUARD CAPITAL MANAGEMENT LLC ($7.4M), MACKENZIE FINANCIAL CORP ($6.4M). Net institutional sentiment: Bullish.

84
Holders
(7 Elite)
$63M
Total Value
71% (77)
Consensus
55 buying - 22 selling
13F: Insider & Congress: Updated regularly
CRBU

Smart Money Verdict

View all
Loading verdict
Held by 84 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Feb 27, 2026 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.7.2%Jul 27, 2026
InsiderKPKelly Timothy PSell $12KFeb 25, 2026
InsiderKPKelly Timothy PSell $6KFeb 24, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.8M(+264.7%)$13.8M0.0%-3.91%
45
Increased
4.2M(+11.7%)$7.4M0.0%-6.25%
31
Increased
3.7M(+287.2%)$6.4M0.0%-6.25%
44
Increased
2.8M(+7.1%)$4.9M0.0%-0.58%
29
Increased
2.4M(+133.3%)$4.2M0.0%-65.43%
43
Increased
1.6M(+285.8%)$2.9M0.0%-36.27%
42
Increased
1.4M(+8.8%)$2.5M0.0%-7.02%
28
Decreased
1M(-40.5%)$1.8M0.0%-15.43%
0
Increased
975,327(+44.9%)$1.7M0.0%-55.08%
35
Increased
775,809(+38.6%)$1.4M0.0%-74.05%
33
Increased
727,115(+0.4%)$1.3M0.0%+2.44%
25
Increased
712,965(+227.4%)$1.3M0.0%-62.35%
41
Unchanged
652,542$1.1M0.0%-93.07%
0
New
613,801$1.1M0.0%-6.25%
38
Increased
606,388(+16.6%)$1.1M0.0%-6.25%
29
Increased
545,755(+208.9%)$960,5290.0%-6.02%
40
Increased
517,371(+99.6%)$910,5730.0%-10.57%
40
Increased
410,979(+14.5%)$723,3230.0%+4.52%
28
Decreased
375,686(-68.8%)$661,2050.0%-3.50%
0
Decreased
322,875(-14.3%)$568,2600.0%+3.13%
0

Showing 1-20 of 93

1 / 5
CRBUCRBUCARIBOU BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used